Amrize Ltd (AMRZ) insider filing shows director owning 4,958 shares

Rhea-AI Filing Summary

Amrize Ltd (AMRZ) director share purchase disclosed. A reporting person serving as a director of Amrize Ltd bought 2,000 ordinary shares on 11/19/2025 at a price of $47.34 per share in an open-market purchase coded "P." After this transaction, the director beneficially owns 4,958 ordinary shares held directly. The filing does not report any transactions in derivative securities.

Insider Trade Summary

Net Buyer: 2,000 shares ($94,680)

Net Buy 1 txn

Insider Gangestad Nicholas C

Role Director

Bought 2,000 shs ($95K)

Type	Security	Shares	Price	Value
Purchase	Ordinary Shares	2,000	$47.34	$95K

Holdings After Transaction: Ordinary Shares — 4,958 shares (Direct)

Footnotes (1)

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Gangestad Nicholas C

(Last) (First) (Middle)

GRAFENAUWEG 8

(Street)

ZUG V8 6300

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Amrize Ltd [ AMRZ ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
11/19/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	11/19/2025		P		2,000	A	$47.34	4,958	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	Hans Weinburger, Attorney-in-Fact	11/20/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Amrize Ltd (AMRZ) report in this Form 4?

A director of Amrize Ltd (AMRZ) reported buying 2,000 ordinary shares on 11/19/2025 in a transaction coded as an open-market purchase ("P").

At what price were the Amrize Ltd (AMRZ) shares purchased?

The director purchased 2,000 ordinary shares of Amrize Ltd at a price of $47.34 per share.

How many Amrize Ltd (AMRZ) shares does the insider own after this transaction?

Following the reported transaction, the director beneficially owns 4,958 ordinary shares of Amrize Ltd, held directly.

What is the insider’s relationship to Amrize Ltd (AMRZ)?

The reporting person is identified as a director of Amrize Ltd, as indicated in the relationship section of the filing.

Were any derivative securities reported in this Amrize Ltd (AMRZ) Form 4?

The Form 4 includes a section for derivative securities, but it does not report any derivative transactions or derivative holdings for the director.

Is the Amrize Ltd (AMRZ) Form 4 filed for one or multiple reporting persons?

The document states that the Form 4 is filed by one reporting person, not by a group.